News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,992 Results
Type
Article (44339)
Company Profile (255)
Press Release (675397)
Multimedia
Podcasts (66)
Webinars (14)
Section
Business (206749)
Career Advice (2141)
Deals (35692)
Drug Delivery (100)
Drug Development (82836)
Employer Resources (175)
FDA (16499)
Job Trends (15134)
News (350468)
Policy (33389)
Tag
Academia (2752)
Accelerated approval (9)
Adcomms (23)
Allergies (97)
Alliances (50340)
ALS (109)
Alzheimer's disease (1481)
Antibody-drug conjugate (ADC) (159)
Approvals (16487)
Artificial intelligence (316)
Autoimmune disease (28)
Automation (18)
Bankruptcy (364)
Best Places to Work (11822)
BIOSECURE Act (19)
Biosimilars (121)
Biotechnology (179)
Bladder cancer (95)
Brain cancer (33)
Breast cancer (365)
Cancer (2888)
Cardiovascular disease (220)
Career advice (1784)
Career pathing (31)
CAR-T (187)
CDC (34)
Cell therapy (505)
Cervical cancer (22)
Clinical research (68042)
Collaboration (1034)
Company closure (3)
Compensation (681)
Complete response letters (22)
COVID-19 (2680)
CRISPR (58)
C-suite (327)
Cystic fibrosis (111)
Data (3004)
Decentralized trials (2)
Denatured (20)
Depression (61)
Diabetes (362)
Diagnostics (6517)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (140)
Drug pricing (128)
Drug shortages (30)
Duchenne muscular dystrophy (128)
Earnings (87660)
Editorial (41)
Employer branding (21)
Employer resources (150)
Events (116136)
Executive appointments (850)
FDA (18151)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (933)
Gene editing (131)
Generative AI (24)
Gene therapy (387)
GLP-1 (826)
Government (4675)
Grass and pollen (5)
Guidances (181)
Healthcare (19333)
Huntington's disease (30)
IgA nephropathy (41)
Immunology and inflammation (151)
Immuno-oncology (9)
Indications (39)
Infectious disease (2860)
Inflammatory bowel disease (148)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (119)
Interviews (339)
IPO (16671)
IRA (47)
Job creations (3699)
Job search strategy (1518)
Kidney cancer (13)
Labor market (52)
Layoffs (507)
Leadership (19)
Legal (8120)
Liver cancer (80)
Lung cancer (405)
Lymphoma (209)
Machine learning (11)
Management (59)
Manufacturing (382)
MASH (97)
Medical device (13630)
Medtech (13635)
Mergers & acquisitions (19738)
Metabolic disorders (886)
Multiple sclerosis (99)
NASH (20)
Neurodegenerative disease (116)
Neuropsychiatric disorders (31)
Neuroscience (2170)
NextGen: Class of 2025 (6732)
Non-profit (4668)
Now hiring (47)
Obesity (448)
Opinion (228)
Ovarian cancer (101)
Pain (109)
Pancreatic cancer (123)
Parkinson's disease (190)
Partnered (22)
Patents (297)
Patient recruitment (162)
Peanut (51)
People (58779)
Pharmaceutical (64)
Pharmacy benefit managers (22)
Phase I (21216)
Phase II (29972)
Phase III (22260)
Pipeline (1626)
Policy (210)
Postmarket research (2675)
Preclinical (9121)
Press Release (68)
Prostate cancer (141)
Psychedelics (36)
Radiopharmaceuticals (255)
Rare diseases (463)
Real estate (6012)
Recruiting (67)
Regulatory (23087)
Reports (50)
Research institute (2444)
Resumes & cover letters (367)
Rett syndrome (9)
RNA editing (9)
RSV (52)
Schizophrenia (90)
Series A (157)
Series B (106)
Service/supplier (12)
Sickle cell disease (61)
Special edition (18)
Spinal muscular atrophy (154)
Sponsored (33)
Startups (3668)
State (2)
Stomach cancer (15)
Supply chain (76)
Tariffs (58)
The Weekly (44)
Vaccines (810)
Venture capital (54)
Weight loss (277)
Women's health (45)
Worklife (18)
Date
Today (60)
Last 7 days (369)
Last 30 days (1949)
Last 365 days (31589)
2025 (16809)
2024 (35649)
2023 (40540)
2022 (51708)
2021 (56271)
2020 (54814)
2019 (47620)
2018 (35904)
2017 (32737)
2016 (32309)
2015 (38369)
2014 (32121)
2013 (27275)
2012 (29434)
2011 (30128)
2010 (28282)
Location
Africa (755)
Alabama (61)
Alaska (7)
Arizona (244)
Arkansas (14)
Asia (39041)
Australia (6489)
California (7436)
Canada (2364)
China (676)
Colorado (323)
Connecticut (318)
Delaware (192)
Europe (85106)
Florida (1118)
Georgia (249)
Hawaii (1)
Idaho (61)
Illinois (651)
India (26)
Indiana (364)
Iowa (17)
Japan (226)
Kansas (108)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1026)
Massachusetts (5546)
Michigan (247)
Minnesota (453)
Mississippi (3)
Missouri (89)
Montana (28)
Nebraska (25)
Nevada (80)
New Hampshire (68)
New Jersey (2082)
New Mexico (29)
New York (2100)
North Carolina (1100)
North Dakota (9)
Northern California (3271)
Ohio (236)
Oklahoma (16)
Oregon (37)
Pennsylvania (1616)
Puerto Rico (18)
Rhode Island (36)
South America (1155)
South Carolina (35)
South Dakota (1)
Southern California (2775)
Tennessee (127)
Texas (1120)
United States (27673)
Utah (220)
Virginia (185)
Washington D.C. (75)
Washington State (643)
West Virginia (4)
Wisconsin (66)
719,992 Results for "ccs associates inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CCS Presents Four Peer-Reviewed Posters at American Diabetes Association’s 85th Scientific Sessions
June 23, 2025
·
4 min read
Press Releases
Precisio Biotix Therapeutics, Inc. (Precisio) Announces a Grant for the Discovery of Novel Engineered Lysin Antimicrobials Targeting Bacterial Vaginosis Associated Pathobionts (BV)
June 16, 2025
·
3 min read
Press Releases
Cocrystal Pharma’s Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5N1 Avian Influenza Strain
May 29, 2025
·
5 min read
BioForest
Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
At the 20th US Human Proteome Organization Congress 2024, Bruker Corporation announced progress in immunopeptidomics, glycoproteomics and other CCS-enabled 4D-proteomics workflows.
March 11, 2024
·
6 min read
BioForest
Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A
Cocrystal Pharma, Inc. announces it has received Pre-Investigational New Drug (Pre-IND) feedback from the U.S. Food and Drug Administration (FDA) regarding CC-42344 as a potential oral treatment for pandemic and seasonal influenza A.
March 19, 2024
·
5 min read
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025
April 25, 2025
·
2 min read
Drug Development
Enrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza
Cocrystal Pharma, Inc. announces completion of enrollment of 78 subjects who were infected with influenza A in a randomized, double-blind, placebo-controlled Phase 2a human challenge clinical study evaluating the safety, tolerability, antiviral and clinical measurements of its novel, broad-spectrum, oral PB2 inhibitor CC-42344.
May 1, 2024
·
5 min read
Press Releases
Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344
December 31, 2024
·
6 min read
Drug Development
CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data
CollPlant Biotechnologies, a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived recombinant human collagen for tissue regeneration and organ manufacturing, announced that it has successfully printed for the first-time breast implants of 200 cc, which are commercial size.
June 6, 2024
·
7 min read
BioCapital
Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions
Senseonics Holdings, Inc. announced plans to host a business update and analyst event during the American Diabetes Association’s 84th Scientific Sessions in Orlando, FL.
June 13, 2024
·
1 min read
1 of 72,000
Next
